NEW YORK, Aug. 31, 2017 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a boutique securities firm headquartered at the Empire State Building in New York City, is investigating Angie's List, Inc. ("Angie's List" or the "Company") (NASDAQ: ANGI) relating to the sale of the Company to affiliates of IAC's HomeAdvisor. As a result of the merger, Angie's List shareholders are only anticipated to receive either 1 share of the newly-created ANGI Homeservices Inc. or $8.50 in cash, subject to proration in exchange for each share of Angie's List.
The investigation focuses on whether Angie's List and its Board of Directors violated securities laws and/or breached their fiduciary duties to the Company's by 1) failing to conduct a fair process 2) whether and by how much this proposed transaction undervalues the Company by and 3) failing to disclose all material financial information in connection with the shareholder meeting on September 29, 2017.
Monteverde & Associates PC is a boutique class action securities and consumer litigation law firm that has recovered millions of dollars and iscommitted to protecting shareholders and consumers from corporate wrongdoing. Monteverde & Associates lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions, whereby they protect investors by recovering money and remedying corporate misconduct.
If you own common stock in Angie's List and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at [email protected] or by telephone at (212) 971-1341.
Contact: Juan E. Monteverde, Esq. MONTEVERDE & ASSOCIATES PC The Empire State Building 350 Fifth Ave. Suite 4405 New York, NY 10118 United States of America [email protected] Tel: (212) 971-1341
Attorney Advertising. (C) 2017 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.